Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. (13th August 2019)

Record Type:: Journal Article
Title:: Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. (13th August 2019)
Main Title:: Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
Authors:: Hortobagyi, G N
Stemmer, S M
Burris, H A
Yap, Y S
Sonke, G S
Paluch-Shimon, S
Campone, M
Petrakova, K
Blackwell, K L
Winer, E P
Janni, W
Verma, S
Conte, P
Arteaga, C L
Cameron, D A
Mondal, S
Su, F
Miller, M
Elmeliegy, M
Germa, C
O'Shaughnessy, J
Abstract:
Is Part Of:: Annals of oncology. Volume 30:Number 11(2019)
Journal:: Annals of oncology
Issue:: Volume 30:Number 11(2019)
Issue Display:: Volume 30, Issue 11 (2019)
Year:: 2019
Volume:: 30
Issue:: 11
Issue Sort Value:: 2019-0030-0011-0000
Page Start:: 1842
Page End:: 1842
Publication Date:: 2019-08-13
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdz215 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12679.xml